Tranche Update on Utah Medical Products, Inc.'s Equity Buyback Plan announced on August 27, 1992.
January 01, 2019 at 01:56 am IST
Share
From October 1, 2018 to December 31, 2018, the company has repurchased 15,000 shares, representing 0.4% for $1.21 million. With this, the company has completed the repurchase of 6,827,547 shares, for $90.08 million under the buyback announced on August 27, 1992.
Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
UTAH MEDICAL PRODUCTS, INC. 
